Insights & Perspectives

Filter by














Therapeutic Area / Research

Search Insights:
Showing 1 to 10 of 30
Filter by: Case Study

Case Study | Jul 17, 2019

Overcoming Barriers to Change

Read more | | Share

Case Study | Jul 17, 2019

Capturing Hearts and Minds

Read more | | Share

Case Study | Jun 26, 2019

Overcoming Barriers at Both the Market and Brand Level

In order to optimize commercial opportunities and overcome barriers at both the market and brand level, companies must develop effective brand strategies for product differentiation to ultimately drive brand growth.

Read more | | Share

Case Study | Feb 15, 2019

Beyond the Guidelines: Uncovering Subtle Differences in Patient Management for a Rare Disease

It’s all in the detail, and that’s especially true for leveraging real life data to better understand the subtle differences in patient management for a rare disease, as well as characterizing the therapeutic response to current therapies.

Read more | | Share

Case Study | Feb 15, 2019

Optimizing Your Clinical Development Plan for Rare Disease

New study effectively captures the patient pathway when patients exit the healthcare system due to lack of therapy

Read more | | Share

Case Study | Nov 11, 2018

Classic Market Research Coupled with Unique Framework Yields Valuable Patient Insights for New Oncology Therapies

Kantar Health recently conducted a breakthrough study about the nutritional journeys of Chinese oncology patients that offers valuable information for the development of advanced therapies.

Read more | | Share

Case Study | Oct 21, 2018

Study Finds That A Simple Adherence Measure Improves Outcomes

A leading pharmaceutical company wanted to understand whether medication non-adherence is associated with glycated hemoglobin (HbA1c) and other non-clinical health outcomes among type 2 diabetes patients using basal insulin analogs.

Read more | | Share

Case Study | Sep 25, 2018

Leveraging the Power of South Korea’s HIRA Database

Kantar Health has the know-how when it comes to using and optimizing the HIRA database, as we’ve built up our experience by communicating with HIRA officials and analyzing HIRA data in South Korea.

Read more | | Share

Case Study | Aug 14, 2018

Identifying Intervention Opportunities Across the Patient Journey

One of the world’s leading pharmaceutical companies wanted to better understand intervention opportunities across the patient journey for immunology diseases and from the patient's perspective.

Read more | | Share

Case Study | Jul 15, 2018

Launching a Pediatric Rare Disease Drug in China

Kantar Health recently implemented a mixed-methods research approach to maximize uptake and patient benefit for a critical metabolic disease medicine across 11 Chinese provinces.

Read more | | Share
Page  < 123 >